Digital Therapeutics in the Treatment of Substance Use Disorders: State of the Science and Vision for the Future (Recording)

Friday, July 7, 2023, 12:00 AM - Monday, July 6, 2026, 11:59 PM, On Demand

Digital therapeutics – software used to prevent, treat, or manage a medical disorder or disease - are redefining the future of healthcare. Digital therapeutics package an entire model of care – that can be delivered with fidelity and in accordance with state-of-the-science best practices – into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings. In this presentation, Dr. Marsch reviews the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world.

  Release Date: July 07, 2023
  Expiration Date: July 06, 2026
  Estimated Time to Complete: 1.5 hours
  Registration Fee: FREE
 *Originally recorded 02/15/2023

View more DEA MATE resources and training accredited by Stanford CME at https://med.stanford.edu/cme/dea.html

AMA PRA Category 1 Credits™ (1.50 hours), ANCC Contact Hours (1.50 hours), APA Continuing Education credits (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Identify the clinical impact that science-based digital therapeutics can have.
2. Discuss the utility of digital data capture (e.g., smartphone sensing) to assess health behavior and provide personalized digital therapeutics.
3. Examine the confluence of factors increasing demand and opportunities for scaling up access to digital therapeutics for behavioral health.

In support of improving patient care, this activity has been planned and implemented by Stanford Medicine and the Northwest Addiction Technology Transfer Center (ATTC). Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
 
Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Material activity for a maximum of 1.5 ANCC contact hours.  

American Psychological Association (APA) 
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. 

Cancellation Policy
Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

Bibliography/Works Cited:

Bickel, W. K., Marsch, L. A., Buchhalter, A. R., & Badger, G. J. (2008). Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Experimental and clinical psychopharmacology, 16(2), 132–143. https://doi.org/10.1037/1064-1297.16.2.132

Epstein, D. H., Willner-Reid, J., Vahabzadeh, M., Mezghanni, M., Lin, J. L., & Preston, K. L. (2009). Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Archives of general psychiatry, 66(1), 88–94. https://doi.org/10.1001/archgenpsychiatry.2008.509

Food and Drug Administration, The. (2022). Policy for Device Software Functions and Mobile Medical Applications. The Food and Drug Administration, Docket No. FDA-2011-D-0530. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-device-software-functions-and-mobile-medical-applications

Guarino, H., Acosta, M., Marsch, L. A., Xie, H., & Aponte-Melendez, Y. (2016). A mixed-methods evaluation of the feasibility, acceptability, and preliminary efficacy of a mobile intervention for methadone maintenance clients. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 30(1), 1–11. https://doi.org/10.1037/adb0000128

Hébert, E. T., Ra, C. K., Alexander, A. C., Helt, A., Moisiuc, R., Kendzor, D. E., Vidrine, D. J., Funk-Lawler, R. K., & Businelle, M. S. (2020). A Mobile Just-in-Time Adaptive Intervention for Smoking Cessation: Pilot Randomized Controlled Trial. Journal of medical Internet research, 22(3), e16907. https://doi.org/10.2196/16907

Marsch L. A. (2021). Digital health data-driven approaches to understand human behavior. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 46(1), 191–196. https://doi.org/10.1038/s41386-020-0761-5

Marsch, L. A., Chen, C. H., Adams, S. R., Asyyed, A., Does, M. B., Hassanpour, S., Hichborn, E., Jackson-Morris, M., Jacobson, N. C., Jones, H. K., Kotz, D., Lambert-Harris, C. A., Li, Z., McLeman, B., Mishra, V., Stanger, C., Subramaniam, G., Wu, W., & Campbell, C. I. (2022). The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations. Frontiers in psychiatry, 13, 871916. https://doi.org/10.3389/fpsyt.2022.871916

Marsch, L. A., Guarino, H., Acosta, M., Aponte-Melendez, Y., Cleland, C., Grabinski, M., Brady, R., & Edwards, J. (2014). Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment. Journal of substance abuse treatment, 46(1), 43–51. https://doi.org/10.1016/j.jsat.2013.08.012

McClure, J. B., Hartzler, A. L., & Catz, S. L. (2016). Design Considerations for Smoking Cessation Apps: Feedback From Nicotine Dependence Treatment Providers and Smokers. JMIR mHealth and uHealth, 4(1), e17. https://doi.org/10.2196/mhealth.5181

Preston, K. L., Kowalczyk, W. J., Phillips, K. A., Jobes, M. L., Vahabzadeh, M., Lin, J. L., Mezghanni, M., & Epstein, D. H. (2018). Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(4), 859–867. https://doi.org/10.1038/npp.2017.275

Scherer, E. A., Metcalf, S. A., Whicker, C. L., Bartels, S. M., Grabinski, M., Kim, S. J., Sweeney, M. A., Lemley, S. M., Lavoie, H., Xie, H., Bissett, P. G., Dallery, J., Kiernan, M., Lowe, M. R., Onken, L., Prochaska, J. J., Stoeckel, L. E., Poldrack, R. A., MacKinnon, D. P., & Marsch, L. A. (2022). Momentary Influences on Self-Regulation in Two Populations With Health Risk Behaviors: Adults Who Smoke and Adults Who Are Overweight and Have Binge-Eating Disorder. Frontiers in digital health, 4, 798895. https://doi.org/10.3389/fdgth.2022.798895

Shiffman, S., & Waters, A. J. (2004). Negative affect and smoking lapses: a prospective analysis. Journal of consulting and clinical psychology, 72(2), 192–201. https://doi.org/10.1037/0022-006X.72.2.192

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.